Comparison Overview

Millionaire

VS

Precision Medicine Online

Millionaire

Largo della Crocetta 2, Milan, 20122, IT
Last Update: 2025-11-21
Between 750 and 799

Millionaire, da oltre trent'anni, è il magazine italiano di riferimento per chi fa impresa, innovazione e cerca idee e risorse per avviare una propria attività. Millionaire è la prima rivista in Italia che parla di business con un linguaggio semplice, contenuti seri e verificati. Si rivolge non solo a coloro che hanno un’attività in proprio, ma a tutti coloro che ricercano un’informazione pratica e di servizio. Idee concretamente realizzabili con i consigli e i riferimenti per passare direttamente dall’idea al “fare”. Su Millionaire, in edicola e online, si trovano idee e opportunità per avviare attività tradizionali, ma soprattutto innovative, stimolate dalle necessità e dai trend di un mondo che evolve, da bisogni diffusi di prodotti e servizi al passo coi tempi. Le notizie, le inchieste e i servizi propongono casi aziendali e storie di chi è riuscito a realizzare il proprio obiettivo. Ma si parla anche di tecniche di vendita e gestione, motivazione, lavoro e opportunità professionali, accesso ai finanziamenti, franchising come volano di attività indipendenti in logiche di rete. Di tecnologia, consumi, sport, tempo libero e tendenze. Di obiettivi personali e imprenditoriali, di mete e Paesi dove vivere e fare affari.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 249
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Precision Medicine Online

None, None, New York, New York, US, 10004
Last Update: 2025-11-25

Precision Medicine Online is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a business unit of Crain Communications. Precision Medicine Online launched in 2023 as an expansion of Precision Oncology News, which was created in 2019 to cover the application of genomic sequencing and other biomarker-driven approaches to guide cancer treatment. While oncology has led the way in adopting molecularly informed approaches to diagnostics, monitoring, and treatment, GenomeWeb is committed to informing our readers about the adoption of precision medicine in all disease areas, and this relaunch reflects this broader scope of coverage. Our dedicated online newsroom tracks the industry players and healthcare systems driving the adoption of precision medicine in oncology, rare disease, cardiovascular disease, autoimmune disease, pharmacogenomics, and more; regulatory, policy, legal, and ethical issues affecting the field; and the challenges of implementing precision medicine as the standard of care.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: None
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/millionaire.jpeg
Millionaire
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/precision-medicine-online.jpeg
Precision Medicine Online
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Millionaire
100%
Compliance Rate
0/4 Standards Verified
Precision Medicine Online
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Millionaire in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Precision Medicine Online in 2025.

Incident History — Millionaire (X = Date, Y = Severity)

Millionaire cyber incidents detection timeline including parent company and subsidiaries

Incident History — Precision Medicine Online (X = Date, Y = Severity)

Precision Medicine Online cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/millionaire.jpeg
Millionaire
Incidents

No Incident

https://images.rankiteo.com/companyimages/precision-medicine-online.jpeg
Precision Medicine Online
Incidents

No Incident

FAQ

Both Millionaire company and Precision Medicine Online company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

Historically, Precision Medicine Online company has disclosed a higher number of cyber incidents compared to Millionaire company.

In the current year, Precision Medicine Online company and Millionaire company have not reported any cyber incidents.

Neither Precision Medicine Online company nor Millionaire company has reported experiencing a ransomware attack publicly.

Neither Precision Medicine Online company nor Millionaire company has reported experiencing a data breach publicly.

Neither Precision Medicine Online company nor Millionaire company has reported experiencing targeted cyberattacks publicly.

Neither Millionaire company nor Precision Medicine Online company has reported experiencing or disclosing vulnerabilities publicly.

Neither Millionaire nor Precision Medicine Online holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Millionaire company nor Precision Medicine Online company has publicly disclosed detailed information about the number of their subsidiaries.

Neither Millionaire nor Precision Medicine Online holds SOC 2 Type 1 certification.

Neither Millionaire nor Precision Medicine Online holds SOC 2 Type 2 certification.

Neither Millionaire nor Precision Medicine Online holds ISO 27001 certification.

Neither Millionaire nor Precision Medicine Online holds PCI DSS certification.

Neither Millionaire nor Precision Medicine Online holds HIPAA certification.

Neither Millionaire nor Precision Medicine Online holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.